These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10216105)

  • 1. Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma.
    López-Guillermo A; Cabanillas F; McDonnell TI; McLaughlin P; Smith T; Pugh W; Hagemeister F; Rodríguez MA; Romaguera JE; Younes A; Sarris AH; Preti HA; Lee MS
    Blood; 1999 May; 93(9):3081-7. PubMed ID: 10216105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and clinical significance of bcl-2/IgH rearrangements in follicular lymphoma.
    Montoto S; López-Guillermo A; Colomer D; Esteve J; Bosch F; Ferrer A; Villamor N; Moreno C; Campo E; Montserrat E
    Leuk Lymphoma; 2003 Jan; 44(1):71-6. PubMed ID: 12691144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21).
    Ha CS; Tucker SL; Lee MS; McLaughlin P; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):727-32. PubMed ID: 11172955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of t(14;18) translocation breakpoint site with clinical characteristics in follicular lymphoma.
    Panjan M; Boltezar L; Novakovic S; Kokovic I; Jezersek Novakovic B
    Radiol Oncol; 2023 Dec; 57(4):487-492. PubMed ID: 37439703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of BCL-2 gene rearrangements in Argentinean non-Hodgkin lymphoma patients: increased frequency of breakpoints outside of MBR and MCR.
    Noriega MF; De Brasi C; Narbaitz M; Slavutsky I
    Blood Cells Mol Dis; 2004; 32(1):232-9. PubMed ID: 14757440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 rearrangements with breakpoints in both vcr and mbr in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.
    Merup M; Spasokoukotskaja T; Einhorn S; Smith CI; Gahrton G; Juliusson G
    Br J Haematol; 1996 Mar; 92(3):647-52. PubMed ID: 8616030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of BCL2 breakpoints in follicular lymphoma and correlation with clinical features: specific subtypes or same disease?
    Buchonnet G; Jardin F; Jean N; Bertrand P; Parmentier F; Tison S; Lepretre S; Contentin N; Lenain P; Stamatoullas-Bastard A; Tilly H; Bastard C
    Leukemia; 2002 Sep; 16(9):1852-6. PubMed ID: 12200703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of t(14;18) polymerase chain reaction-positive cells in highly purified CD34+ cells and their CD19 subsets in patients with follicular lymphoma.
    Voso MT; Hohaus S; Moos M; Haas R
    Blood; 1997 May; 89(10):3763-8. PubMed ID: 9160682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive.
    Bosga-Bouwer AG; van Imhoff GW; Boonstra R; van der Veen A; Haralambieva E; van den Berg A; de Jong B; Krause V; Palmer MC; Coupland R; Kluin PM; van den Berg E; Poppema S
    Blood; 2003 Feb; 101(3):1149-54. PubMed ID: 12529293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of molecular response in indolent follicular lymphomas.
    López-Guillermo A; Cabanillas F; McLaughlin P; Smith T; Hagemeister F; Rodríguez MA; Romaguera JE; Younes A; Sarris AH; Preti HA; Pugh W; Lee MS
    Blood; 1998 Apr; 91(8):2955-60. PubMed ID: 9531606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ''Minor'' BCL2 breakpoints in follicular lymphoma: frequency and correlation with grade and disease presentation in 236 cases.
    Weinberg OK; Ai WZ; Mariappan MR; Shum C; Levy R; Arber DA
    J Mol Diagn; 2007 Sep; 9(4):530-7. PubMed ID: 17652637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative PCR detection of t(14;18) bcl-2/JH fusion sequences in follicular lymphoma patients: comparison of peripheral blood and bone marrow aspirate samples.
    Bowman A; Jones D; Medeiros LJ; Luthra R
    J Mol Diagn; 2004 Nov; 6(4):396-400. PubMed ID: 15507680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of screening the intermediate cluster region of the bcl2 gene in follicular lymphomas by PCR.
    Batstone PJ; Goodlad JR
    J Clin Pathol; 2005 Jan; 58(1):81-2. PubMed ID: 15623489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characteristics and prognostic significance of Bcl-2/IgH gene rearrangement in Serbian follicular lymphoma patients.
    Radojkovic M; Ristic S; Colovic M; Cemerikic-Martinovic V; Radojkovic D; Krtolica K
    Neoplasma; 2008; 55(5):421-7. PubMed ID: 18665753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of t(14;18) positive cells in blood and bone marrow does not predict outcome in follicular lymphoma.
    Paszkiewicz-Kozik E; Kulik J; Fabisiewicz A; Tysarowski A; Kraszewska E; Siedlecki JA; Walewski J
    Med Oncol; 2009; 26(1):16-21. PubMed ID: 18470485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. t(14;18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region.
    Gu K; Fu K; Jain S; Liu Z; Iqbal J; Li M; Sanger WG; Weisenburger DD; Greiner TC; Aoun P; Dave BJ; Chan WC
    Mod Pathol; 2009 Sep; 22(9):1251-7. PubMed ID: 19465899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-6 p53 mutations in lymphomas carrying the bcl-2/Jh rearrangement.
    Bellido M; Capello D; Altés A; Estivill C; Gaidano G; Pujol R; Bordes R; Baiget M; Saglio G; Sierra J; Nomdedéu JF
    Haematologica; 2002 Sep; 87(9):908-17. PubMed ID: 12217802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
    Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
    Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study.
    Hill ME; MacLennan KA; Cunningham DC; Vaughan Hudson B; Burke M; Clarke P; Di Stefano F; Anderson L; Vaughan Hudson G; Mason D; Selby P; Linch DC
    Blood; 1996 Aug; 88(3):1046-51. PubMed ID: 8704213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative real-time polymerase chain reaction for detection of circulating cells with t(14;18) in volunteer blood donors and patients with follicular lymphoma.
    Tsimberidou AM; Jiang Y; Ford RJ; Lichtiger B; Medeiros LJ; McLaughlin P; Cabanillas F; Sarris AH
    Leuk Lymphoma; 2002 Aug; 43(8):1589-98. PubMed ID: 12400601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.